NCT00807118 - Phase 1, Single Dose, Crossover Study to Determine Bioequivalence and to Investigate Food Effect | Biotech Hunter

Enrollment

108

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions

Therapeutic EquivalencyFood

Interventions

DRUG

Fesoterodine

Single dose of 2 x 4 mg tab in formulation F under fed condition

DRUG

Fesoterodine

Single dose of 1 x 8 mg tab in formulation F under fed condition

DRUG

Fesoterodine

Single dose of 1 x 8 mg tab in formulation E(1) under fed condition

DRUG

Fesoterodine

Single dose of 1 x 8 mg tab in formulation F under fed condition

DRUG

Fesoterodine

Single dose of 2 x 4 mg tab in formulation F under fasted condition

DRUG

Fesoterodine

Single dose of 1 x 8 mg tab in formulation F under fasted condition

Trial Locations (1)

Pfizer Investigational Site, Shinjuku-ku